U.S. Capital Wealth Advisors LLC Lowers Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

U.S. Capital Wealth Advisors LLC lowered its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 0.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 88,154 shares of the real estate investment trust’s stock after selling 441 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Omega Healthcare Investors were worth $3,588,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of OHI. Daiwa Securities Group Inc. increased its position in shares of Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Omega Healthcare Investors during the second quarter worth $20,962,000. BROOKFIELD Corp ON acquired a new position in shares of Omega Healthcare Investors during the first quarter worth $16,446,000. Dimensional Fund Advisors LP increased its position in shares of Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after purchasing an additional 272,299 shares in the last quarter. Finally, Sei Investments Co. increased its position in shares of Omega Healthcare Investors by 150.8% in the 2nd quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock valued at $10,233,000 after acquiring an additional 179,623 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $41.62 on Thursday. The business’s 50-day moving average is $39.93 and its two-hundred day moving average is $35.47. The company has a market capitalization of $10.28 billion, a P/E ratio of 37.50, a P/E/G ratio of 1.34 and a beta of 1.00. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $41.76.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company had revenue of $252.70 million for the quarter, compared to analyst estimates of $205.92 million. During the same period in the prior year, the business posted $0.74 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 17.5% on a year-over-year basis. Research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Insider Transactions at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on OHI. BMO Capital Markets upped their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Truist Financial upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price on the stock. Finally, Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their target price for the company from $34.00 to $35.00 in a research report on Thursday, July 25th. Eight equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $37.80.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.